Medical and Pharmaceutical
A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "psilocybin"
Industry update
The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds
Canada
Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program
Psychedelics
With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field
Industry update
After raising $8.1M, the Calgary company filed 12 patents and launched a candidate selection program for novel psychedelic mental health treatments
Analysis
Following a surge of interest, ibogaine therapy in the country disappeared. But recent signs show regulators are warming to the promising plant
Industry update
Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments
Industry update
Part of the program involves trainees taking psilocybin themselves
Investment Ideas
Through its university partnership, the firm wants to attract big pharma backers by making 100,000s of novel psychedelic derivatives for new precision medicine
Psychedelics
A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound
